This item requires a subscription to Journal of Leukocyte Biology.
Cover
Full Text (PDF)

This review highlights how the blockade of the co-stimulatory HVEM/LIGHT interaction or agonist signaling through the inhibitory BTLA and CD160 receptors could contribute to the control of deleterious immune responses.

To view this item, select one of the options below: